← All trials
NCT04447781
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 15, 2020
- Primary completion
- Feb 22, 2022
- Completion date
- Feb 22, 2022
- First posted
- Jun 25, 2020
- Last posted
- Aug 19, 2020
- Enrollment
- 160
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- International Vaccine InstituteLead sponsor
- Seoul National UniversityOverall official - principal investigator
- Seoul National UniversityOverall official - principal investigator
- Inovio PharmaceuticalsCollaborator
- Coalition for Epidemic Preparedness InnovationsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.